These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8147953)

  • 1. Efficacy and quality in clinical trials. Requirements to the investigator site. European Economic Community.
    Friederichs E; Spitzer SG; Bach R
    Arzneimittelforschung; 1994 Feb; 44(2):182-4. PubMed ID: 8147953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of the GCP guidelines in Europe.
    Geussenhainer S
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Good clinical practice. Requirements for clinical documentation on the introduction of new drugs].
    Dirach J
    Ugeskr Laeger; 1990 Apr; 152(14):992-4. PubMed ID: 2183456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience as a model hospital for new good clinical practice (GCP) regulations].
    Tanaka S
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1467-73. PubMed ID: 9725036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objectives of QC systems and QA function in clinical research.
    Poy E
    Qual Assur; 1993 Dec; 2(4):326-31. PubMed ID: 7952966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of good clinical practice in the EEC and in Germany.
    Anhalt E
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].
    Hvidberg EF
    Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experiences with GLP/GCP from the pharmaceutical industry's viewpoint.
    Legler UF
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):233-6. PubMed ID: 8361261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Academic investigator-initiated trials and the challenge of sponsor responsibility: the Cologne Sponsor Model.
    Georgias C; Grunow A; Olderog M; May A; Paulus U
    Clin Trials; 2012 Dec; 9(6):781-7. PubMed ID: 23104975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality assurance in clinical studies: a necessity].
    Boll M; Binder J; Siegel A; Grundmann R
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):65-72. PubMed ID: 2278157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaceutical aspects of clinical trials: concepts of pharmacokinetic investigations].
    Czejka M
    Onkologie; 2008; 31 Suppl 2():29-33. PubMed ID: 18487866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical researchers and the pharmaceutical industry. Usefulness and need for an independent steering committee].
    Van Gijn J; Algra A
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1477-9. PubMed ID: 10443264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.